4.7 Article

Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel

Journal

BIOMEDICINES
Volume 9, Issue 1, Pages -

Publisher

MDPI
DOI: 10.3390/biomedicines9010075

Keywords

KCNA1; myokymia; neuromyotonia; muscle hypertrophy; ataxia; creatine kinase; patch clamp; molecular modeling

Funding

  1. Ataxia UK
  2. University of Bari (Fondi di Ateneo)
  3. Canadian Institutes of Health Research (CIHR) [PJT-169, 160]
  4. Natural Sciences and Engineering Research Council (NSERC) [RGPIN-2017-06871]
  5. Telethon [GUP19, 002]
  6. Malta Council for Science and Technology [E20LG42]

Ask authors/readers for more resources

Mutations in the KCNA1 gene are classically associated with episodic ataxia type 1, but can also lead to various symptoms including neuromyotonia. A novel de novo variant, T268K, was identified in this study, disrupting Kv1.1 function and causing neuromyotonia, muscle hypertrophy, and skeletal deformities.
The KCNA1 gene encodes the alpha subunit of the voltage-gated Kv1.1 potassium channel that critically regulates neuronal excitability in the central and peripheral nervous systems. Mutations in KCNA1 have been classically associated with episodic ataxia type 1 (EA1), a movement disorder triggered by physical and emotional stress. Additional features variably reported in recent years include epilepsy, myokymia, migraine, paroxysmal dyskinesia, hyperthermia, hypomagnesemia, and cataplexy. Interestingly, a few individuals with neuromyotonia, either isolated or associated with skeletal deformities, have been reported carrying variants in the S2-S3 transmembrane segments of Kv1.1 channels in the absence of any other symptoms. Here, we have identified by whole-exome sequencing a novel de novo variant, T268K, in KCNA1 in a boy displaying recurrent episodes of neuromyotonia, muscle hypertrophy, and skeletal deformities. Through functional analysis in heterologous cells and structural modeling, we show that the mutation, located at the extracellular end of the S3 helix, causes deleterious effects, disrupting Kv1.1 function by altering the voltage dependence of activation and kinetics of deactivation, likely due to abnormal interactions with the voltage sensor in the S4 segment. Our study supports previous evidence suggesting that specific residues within the S2 and S3 segments of Kv1.1 result in a distinctive phenotype with predominant musculoskeletal presentation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available